Bml Capital Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 27Value: $123.6MLatest: 2025Q1

BML Capital Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 27 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "TIL",
  "ANTX",
  "VRCA",
  "THRD",
  "SAGE",
  "ADVM",
  "ALMS",
  "ATHA",
  "ASTC",
  "EPIX",
  "LVTX",
  "LSTA",
  "MIST",
  "NXTC",
  "PMVP",
  "TSBX",
  "WHWK",
  "ORMP",
  "ACRS",
  null,
  "CNTB",
  "ELEV",
  "IKNA",
  "HLVX",
  "KZR",
  "VTGN",
  "AVIR"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-07
Total Holdings: 27
Total Value: 123560622
Accession Number: 0001754960-25-000280
Form Type: 13F-HR
CIK: bml-capital-management
Manager Name: Bml-Capital-Management

Data Enrichment

96% identified

26 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

27 positions • $123.6M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Atea Pharmaceuticals, Inc.

AVIR|04683R106

Shares:7.6M

Value:$22.8M

% of Portfolio:18.4% ($22.8M/$123.6M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:14.3M

Value:$21.8M

% of Portfolio:17.6% ($21.8M/$123.6M)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:3.8M

Value:$13.3M

% of Portfolio:10.7% ($13.3M/$123.6M)

Adverum Biotechnologies, Inc.

ADVM|00773U207

Shares:2.7M

Value:$12.0M

% of Portfolio:9.7% ($12.0M/$123.6M)

AN2 Therapeutics, Inc.

ANTX|037326105

Shares:5.7M

Value:$7.8M

% of Portfolio:6.3% ($7.8M/$123.6M)

Instil Bio, Inc.

TIL|45783C200

Shares:416.7K

Value:$7.2M

% of Portfolio:5.9% ($7.2M/$123.6M)

ESSA Pharma Inc.

EPIX|29668H708

Shares:4.2M

Value:$6.7M

% of Portfolio:5.4% ($6.7M/$123.6M)

ORAMED PHARMACEUTICALS INC.

ORMP|68403P203

Shares:3.0M

Value:$6.5M

% of Portfolio:5.2% ($6.5M/$123.6M)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:3.7M

Value:$4.7M

% of Portfolio:3.8% ($4.7M/$123.6M)

PMV Pharmaceuticals, Inc.

PMVP|69353Y103

Shares:3.7M

Value:$4.1M

% of Portfolio:3.3% ($4.1M/$123.6M)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:1.9M

Value:$3.4M

% of Portfolio:2.7% ($3.4M/$123.6M)

LAVA Therapeutics NV

LVTX|N51517105

Shares:2.0M

Value:$2.5M

% of Portfolio:2.0% ($2.5M/$123.6M)

Kezar Life Sciences, Inc.

KZR|49372L209

Shares:408.1K

Value:$2.0M

% of Portfolio:1.6% ($2.0M/$123.6M)

Elevation Oncology, Inc.

ELEV|28623U101

Shares:5.9M

Value:$1.5M

% of Portfolio:1.2% ($1.5M/$123.6M)

ASTROTECH Corp

ASTC|046484309

Shares:220.4K

Value:$1.4M

% of Portfolio:1.2% ($1.4M/$123.6M)

Connect Biopharma Holdings Ltd

CNTB|207523101

Shares:2.1M

Value:$1.2M

% of Portfolio:0.9% ($1.2M/$123.6M)

Sage Therapeutics, Inc.

SAGE|78667J108

Shares:135.1K

Value:$1.1M

% of Portfolio:0.9% ($1.1M/$123.6M)

Athira Pharma, Inc.

ATHA|04746L104

Shares:3.2M

Value:$911.9K

% of Portfolio:0.7% ($911.9K/$123.6M)

Milestone Pharmaceuticals Inc.

MIST|59935V107

Shares:1.1M

Value:$909.0K

% of Portfolio:0.7% ($909.0K/$123.6M)

LISATA THERAPEUTICS, INC.

LSTA|128058302

Shares:216.9K

Value:$509.6K

% of Portfolio:0.4% ($509.6K/$123.6M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Atea Pharmaceuticals, Inc.(AVIRcusip04683R106)	7.6M	QoQ +0.01% (-1.5K) YoY +37.44% (+2.1M)	All Managers (Combined)	$22.8M	18.4% ($22.8M/$123.6M)	QoQ -10.72% (-$2.7M) YoY +1.72% (+$385.0K)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	14.3M	QoQ 0.00% (-0) YoY +51.66% (+4.9M)	All Managers (Combined)	$21.8M	17.6% ($21.8M/$123.6M)	QoQ -38.30% (-$13.5M) YoY +87.13% (+$10.2M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	3.8M	QoQ NEW(+3.8M) YoY NEW(+3.8M)	All Managers (Combined)	$13.3M	10.7% ($13.3M/$123.6M)	QoQ NEW(+$13.3M) YoY NEW(+$13.3M)
Adverum Biotechnologies, Inc.(ADVMcusip00773U207)	2.7M	QoQ +20.91% (+474.3K) YoY +229.16% (+1.9M)	All Managers (Combined)	$12.0M	9.7% ($12.0M/$123.6M)	QoQ +13.14% (+$1.4M) YoY +1.72% (+$203.7K)
AN2 Therapeutics, Inc.(ANTXcusip037326105)	5.7M	QoQ 0.00% (-0) YoY NEW(+5.7M)	All Managers (Combined)	$7.8M	6.3% ($7.8M/$123.6M)	QoQ -1.44% (-$115.0K) YoY NEW(+$7.8M)
Instil Bio, Inc.(TILcusip45783C200)	416.7K	QoQ +4.18% (-16.7K) YoY +19.49% (+68.0K)	All Managers (Combined)	$7.2M	5.9% ($7.2M/$123.6M)	QoQ -5.26% (-$401.7K) YoY +92.07% (+$3.5M)
ESSA Pharma Inc.(EPIXcusip29668H708)	4.2M	QoQ 0.00% (-0) YoY NEW(+4.2M)	All Managers (Combined)	$6.7M	5.4% ($6.7M/$123.6M)	QoQ -11.73% (-$886.5K) YoY NEW(+$6.7M)
ORAMED PHARMACEUTICALS INC.(ORMPcusip68403P203)	3.0M	QoQ +14.25% (+376.8K) YoY +257.69% (+2.2M)	All Managers (Combined)	$6.5M	5.2% ($6.5M/$123.6M)	QoQ +1.03% (+$66.1K) YoY +162.14% (+$4.0M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	3.7M	QoQ +3.48% (-124.9K) YoY NEW(+3.7M)	All Managers (Combined)	$4.7M	3.8% ($4.7M/$123.6M)	QoQ -19.23% (-$1.1M) YoY NEW(+$4.7M)
PMV Pharmaceuticals, Inc.(PMVPcusip69353Y103)	3.7M	QoQ +8.10% (-280.9K) YoY +186.84% (+2.4M)	All Managers (Combined)	$4.1M	3.3% ($4.1M/$123.6M)	QoQ -21.96% (-$1.1M) YoY +83.91% (+$1.9M)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	1.9M	QoQ -9.98% (-209.8K) YoY NEW(+1.9M)	All Managers (Combined)	$3.4M	2.7% ($3.4M/$123.6M)	QoQ -49.21% (-$3.3M) YoY NEW(+$3.4M)
LAVA Therapeutics NV(LVTXcusipN51517105)	2.0M	QoQ NEW(+2.0M) YoY NEW(+2.0M)	All Managers (Combined)	$2.5M	2.0% ($2.5M/$123.6M)	QoQ NEW(+$2.5M) YoY NEW(+$2.5M)
Kezar Life Sciences, Inc.(KZRcusip49372L209)	408.1K	QoQ +738.61% (+359.5K) YoY NEW(+408.1K)	All Managers (Combined)	$2.0M	1.6% ($2.0M/$123.6M)	QoQ +508.99% (+$1.7M) YoY NEW(+$2.0M)
Elevation Oncology, Inc.(ELEVcusip28623U101)	5.9M	QoQ NEW(+5.9M) YoY NEW(+5.9M)	All Managers (Combined)	$1.5M	1.2% ($1.5M/$123.6M)	QoQ NEW(+$1.5M) YoY NEW(+$1.5M)
ASTROTECH Corp(ASTCcusip046484309)	220.4K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.4M	1.2% ($1.4M/$123.6M)	QoQ -3.57% (-$52.9K) YoY -27.59% (-$544.4K)
Connect Biopharma Holdings Ltd(CNTBcusip207523101)	2.1M	QoQ 0.00% (-0) YoY +1.54% (-31.9K)	All Managers (Combined)	$1.2M	0.9% ($1.2M/$123.6M)	QoQ -60.14% (-$1.7M) YoY -67.90% (-$2.4M)
Sage Therapeutics, Inc.(SAGEcusip78667J108)	135.1K	QoQ NEW(+135.1K) YoY NEW(+135.1K)	All Managers (Combined)	$1.1M	0.9% ($1.1M/$123.6M)	QoQ NEW(+$1.1M) YoY NEW(+$1.1M)
Athira Pharma, Inc.(ATHAcusip04746L104)	3.2M	QoQ +15.30% (-424.8K) YoY +255.62% (-2.3M)	All Managers (Combined)	$911.9K	0.7% ($911.9K/$123.6M)	QoQ -44.00% (-$716.7K) YoY -63.02% (-$1.6M)
Milestone Pharmaceuticals Inc.(MISTcusip59935V107)	1.1M	QoQ 0.00% (-0) YoY +87.42% (-529.9K)	All Managers (Combined)	$909.0K	0.7% ($909.0K/$123.6M)	QoQ -66.09% (-$1.8M) YoY -16.22% (-$176.0K)
LISATA THERAPEUTICS, INC.(LSTAcusip128058302)	216.9K	QoQ -23.82% (-67.8K) YoY -23.82% (-67.8K)	All Managers (Combined)	$509.6K	0.4% ($509.6K/$123.6M)	QoQ -39.92% (-$338.7K) YoY -42.62% (-$378.6K)